Entry |
|
Symbol |
NFKBIB
|
Name |
NF-kappa-B inhibitor beta
|
Pathway |
map04621 | NOD-like receptor signaling pathway |
map04622 | RIG-I-like receptor signaling pathway |
map04658 | Th1 and Th2 cell differentiation |
map04660 | T cell receptor signaling pathway |
map04662 | B cell receptor signaling pathway |
map04920 | Adipocytokine signaling pathway |
map05130 | Pathogenic Escherichia coli infection |
map05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer |
|
Brite |
KEGG Orthology (KO) [BR:ko00001]
09150 Organismal Systems
09151 Immune system
04621 NOD-like receptor signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
04622 RIG-I-like receptor signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
04623 Cytosolic DNA-sensing pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
04660 T cell receptor signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
04658 Th1 and Th2 cell differentiation
K02581 NFKBIB; NF-kappa-B inhibitor beta
04659 Th17 cell differentiation
K02581 NFKBIB; NF-kappa-B inhibitor beta
04662 B cell receptor signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
04062 Chemokine signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
09152 Endocrine system
04920 Adipocytokine signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
09156 Nervous system
04722 Neurotrophin signaling pathway
K02581 NFKBIB; NF-kappa-B inhibitor beta
09160 Human Diseases
09161 Cancer: overview
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer
K02581 NFKBIB; NF-kappa-B inhibitor beta
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
K02581 NFKBIB; NF-kappa-B inhibitor beta
05164 Influenza A
K02581 NFKBIB; NF-kappa-B inhibitor beta
05162 Measles
K02581 NFKBIB; NF-kappa-B inhibitor beta
05169 Epstein-Barr virus infection
K02581 NFKBIB; NF-kappa-B inhibitor beta
09171 Infectious disease: bacterial
05130 Pathogenic Escherichia coli infection
K02581 NFKBIB; NF-kappa-B inhibitor beta
05131 Shigellosis
K02581 NFKBIB; NF-kappa-B inhibitor beta
09174 Infectious disease: parasitic
05145 Toxoplasmosis
K02581 NFKBIB; NF-kappa-B inhibitor beta
05140 Leishmaniasis
K02581 NFKBIB; NF-kappa-B inhibitor beta
09180 Brite Hierarchies
09182 Protein families: genetic information processing
03000 Transcription factors
K02581 NFKBIB; NF-kappa-B inhibitor beta
Transcription factors [BR:ko03000]
Eukaryotic type
beta-Scaffold factors with minor groove contacts
RHR (Rel homology region) Ankyrin only
K02581 NFKBIB; NF-kappa-B inhibitor beta
|
Other DBs |
|
Genes |
» show all
|
Reference |
|
Authors |
Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh S |
Title |
I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. |
Journal |
|
Sequence |
|